
|Articles|December 1, 2006
Transpupillary thermotherapy has high success rate with choroidal melanomas
Rochester, MN-Transpupillary thermotherapy (TTT) caused small choroidal melanoma tumors to regress in most of the patients who were treated with this diode laser therapy. In a study of 40 patients, almost 80% of patients were successfully treated with one application of TTT. Additional therapy with TTT and other modalities was needed to treat some cases of small choroidal melanomas.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
First patient treated in ViaLase’s IDE trial
2
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
3
FDA grants IDE approval to EyeYon Medical for its US clinical study of EndoArt
4
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
5















































.png)


